Furthermore, CD4+ T cells have been shown to mediate direct cytotoxicity against tumor cells through increased production of interferon gamma (IFNγ) and tumor necrosis factor (TNFα in both preclinical models [23,24,25] and patient-derived CD4+ T cells [26]. The gene discussed is CD4; the disease is neoplasm.